疼痛管理市场基础(关键地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00029979
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Pain Management Therapeutics Market Opportunities 2031

Buy Now

市场概览
疼痛是一种令人痛苦的感觉&与现有或潜在的组织损伤相似的情绪感觉。这是一种不舒服的感觉,比如刺痛、刺痛、刺痛或酸痛。疼痛可能是轻微的或剧烈的,也可能是持续的或间歇性的。患者可能会感到全身或某一部位不适,例如背部、腹部、胸部和骨盆。疼痛还可以帮助诊断问题。急性疼痛和慢性疼痛是两种不同类型的疼痛。由于身体状况、受伤或炎症,急性疼痛经常突然出现。它通常是可以治疗和诊断的。通常,它会消失,但偶尔会发展为持续性疼痛。

另一方面,慢性疼痛持续很长时间并可能导致严重的问题。慢性疼痛的主要原因包括神经损伤和损伤、骨骼和关节老化以及其他疾病。一类特定的药物用于长期治疗或控制疼痛及其影响。疼痛过程很复杂,但有几种药物可以通过不同的生理机制发挥作用,从而提供帮助。最常见的止痛药类型是阿片类药物。这些是含有天然和合成阿片类药物的麻醉止痛药。阿片类药物通常用于治疗急性疼痛,例如术后立即不适。此外,用于镇痛的其他阿片类药物包括吗啡、芬太尼、羟考酮和可待因。疼痛的治疗基于疼痛的性质和来源。疼痛管理还包括有助于减轻疼痛的疗法和设备。此外,还有非药物疗法,如针灸、物理疗法,有时还需要手术。

市场范围
“到 2030 年全球疼痛管理治疗市场分析”是对制药行业的专业深入研究,特别关注全球市场趋势分析。该报告旨在概述疼痛管理治疗市场,并按药物类别、适应症、分销渠道和地理位置进行详细的市场细分。该报告提供了领先的疼痛管理治疗市场参与者的市场状况的关键统计数据,并提供了市场的主要趋势和机会。

市场细分
疼痛管理治疗市场规模分为药物类别、适应症、分销渠道和地区。根据药物类别,全球疼痛管理治疗市场分为非甾体抗炎药、麻醉药、抗惊厥药、抗偏头痛药、抗抑郁药、阿片类药物等。按适应症,疼痛管理治疗市场分为关节炎疼痛、神经性疼痛、癌症疼痛、慢性疼痛、术后疼痛、偏头痛、纤维肌痛、骨折等。按分销渠道划分,疼痛管理治疗市场分为医院药房、零售药房和在线药房。

市场动态
驱动因素
疼痛管理治疗市场受到不断增长的需求的有利影响止痛药物、不断上涨的医疗成本、增加医生和患者的疾病知识以及众多的研发项目。根据国家卫生统计数据,每年进行超过 3.1 亿例大型手术,其中 40 至 5000 万例在美国进行,2000 万例在欧洲进行。此外,全球手术数量不断增加,这是推动止痛药使用的主要因素。因此,疼痛管理治疗市场受到与疼痛发生率相关的癌症治疗方法的增加以及使用不同疗法的老年人口不断增加的推动。此外,交通和道路事故的增加会导致相对创伤,从而增加术后疼痛管理的需求。此外,据世界卫生组织估计,每年约有 130 万人死于交通事故。全球约有 20 至 5000 万人遭受非致命伤害,其中许多人因受伤而致残。减轻疼痛管理药物的可用性、易于获取性、知识的增加、成本效益和速度影响着消费者的偏好。然而,疼痛管理治疗市场的扩张受到对药物滥用不断升级的担忧的限制。此外,预计疼痛管理治疗市场将大大受益于基于纳米粒子的疼痛管理的最新发展。


由于改善疼痛护理治疗的可用性、慢性病患者数量的增加、有利保险的可用性政策以及人口老龄化基础的扩大,预计北美疼痛管理治疗市场将占据相当大的收入份额。随着老年人口的增长,由于他们更有可能患上慢性疾病,预计市场将扩大得更快。此外,预计区域和全球公司之间不断增长的合作伙伴关系和协议将有助于目标市场的收入增长。预计在该国运营的多家参与者以及引入新颖解决方案的战略将刺激目标市场的扩张。

亚太地区疼痛管理治疗市场预计将以显着的速度增长预测期内的利率。推动疼痛管理治疗市场增长的主要因素之一是癌症、糖尿病神经病变、骨关节炎和慢性关节炎等疾病患病率的上升。其他重要的驱动因素包括外科手术数量的增加和医疗保健支出的增加。然而,疼痛管理疗法市场的扩张受到仿制药完整性的提高、重磅药物的专利到期以及止痛装置等替代品的可及性等原因的严重限制。此外,处方药物滥用将限制市场的扩张。

市场参与者
该报告涵盖了关键的疼痛管理治疗市场发展,例如有机和无机增长策略。雅培 (Abbott)、阿斯利康 (AstraZeneca)、勃林格殷格翰 (BoehringerIngelheim)、礼来 (Eli Lilly) 等多家公司公司、Mylan NV、辉瑞、Depomed Inc.、Endo International Plc.、葛兰素史克 Plc.、强生公司强生、默克公司Co. Inc.、Novartis AG、Purdue Pharma LP、Teva Pharmaceutical Industries 等公司都专注于有机增长战略,例如产品发布、产品批准以及专利和活动等其他战略。市场上见证的无机增长战略活动包括收购、合作和收购。合作。这些活动为扩大市场参与者的业务和客户群铺平了道路。随着全球市场对疼痛管理治疗的需求不断增长,预计疼痛管理治疗市场的市场参与者将拥有利润丰厚的增长机会。

全球疼痛管理治疗市场的主要发展

    2022 年 10 月,帕克实验室, Inc 推出了两种高效的局部疼痛管理霜 Helix Tri-Active 和 Helix with CBD,为对抗慢性疼痛的患者提供了新的选择。2022 年 8 月,Myovant Sciences 和辉瑞的 MYFEMBREE 获得美国 FDA 批准,这是一种每日一次的治疗方法,用于治疗与子宫内膜异位症相关的中度至重度疼痛。2021 年 10 月,Esteve Pharmaceuticals 的 SEGLENTIS 获得美国食品和药物管理局 (FDA) 批准,该药物用于治疗急性疼痛患者严重到需要阿片类镇痛剂,但其他方法无法充分控制。2021年,美国NeuroPace, Inc.推出Senza Omnia脊髓刺激系统,用于治疗慢性疼痛。预计将协助该公司拓展产品线并提高利润率。

该报告还包括主要公司的概况、SWOT 分析以及疼痛管理治疗市场增长的市场策略。此外,该报告还重点介绍了领先的行业参与者的信息例如公司简介、组件和提供的服务、过去三年的财务信息以及过去五年的主要发展。

Insight Partner 的专业研究和分析团队由经验丰富的专业人士组成,拥有先进的统计专业知识,并在当前研究中提供各种定制选项。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies
1. NOVARTIS AG
2. ELI LILLY AND COMPANY
3. ABBOTT LABORATORIES
4. ENDO HEALTH SOLUTIONS, INC
5. PURDUE PHARMA L.P.
6. PFIZER, INC.
7. MYLAN NV.
8. MERCK AND CO. INC
9. JOHNSON AND JOHNSON
10. GLAXOSMITHKLINE PLC.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..